Radiopharmaceuticals Expert Joins Lineup for ASNC’s May 5 Congressional Briefing on Improving Access to Cardiac Imaging

PharmaLogic President and CEO Etienne Montagut will speak on radiopharmaceutical supply at ASNC’s May 5 congressional briefing. The event is open to the public.

Etienne Montagut, president and CEO of PharmaLogic, will present at ASNC’s upcoming congressional briefing on Capitol Hill.

PharmaLogic is a global contract development and manufacturing organization specializing in diagnostic and therapeutic radiopharmaceuticals, including those used in nuclear cardiology.

Mr. Montagut has more than 25 years of senior leadership experience in the pharmaceutical sector, including executive positions at Lantheus and GE HealthCare. He will join the following physician experts in a discussion of how to overcome challenges that can impede patients’ access to cardiac imaging.

ASNC’s May 5 congressional briefing will feature these physicians addressing potential solutions for barriers that impede access to cardiac nuclear imaging.

Topics will include payment instability, prior authorization, and radiopharmaceutical supply disruptions. View the agenda.

The briefing, titled From Symptoms to Solutions: Removing Obstacles to Cardiac Nuclear Imaging, will be held Tuesday, May 5, from 12:00 to 1:00 PM (ET) in room 2043 on the ground floor of the Rayburn House of Representatives Office Building.

The briefing is open to the public and will include lunch for attendees.

Also on Capitol Hill: ASNC Leaders Meeting with Members of Congress and Legislative Staff

In addition to the congressional briefing, ASNC will lead a group of physician advocates to meetings with lawmakers. Their meetings will focus on Medicare payment reform, including the impact of recent cuts to reimbursement for PYP imaging; prior authorization; and other barriers that affect patients’ access to care. Watch for news from the meetings.

RSVP for Briefing